Lucid Diagnostics
LUCD
$0.68
Share price
0.60%
Change (1 day)
-53.53%
Change (1 year)
Categories
Lucid Diagnostics (LUCD) - P/B ratio
P/B ratio as of April 2024 : 12.9
According to Lucid Diagnostics's latest financial reports the company has a price-to-book ratio of 12.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lucid Diagnostics - P/B ratio (from 2021 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -26.2 | -1233.65% |
| 2022-12-31 | 2.31 | -36.09% |
| 2021-12-31 | 3.61 | |
| 2020-12-31 | N/A |